Boosting tumor-infiltrating lymphocyte therapy with the power of B cells
The Future of Immunotherapy: Enhancing TIL Therapy New research from Moffitt Cancer Center suggests a promising future for cancer immunotherapy, specifically TIL therapy. By activating B cells through the use of CD40L, scientists have discovered a way to significantly boost the effectiveness and efficiency of this innovative treatment. As we dive deeper into this development, … Read more